- Generic name
- Brivaracetam
- Strength
- 10 mg/ml
- Dosage form
- Oral Solution
- Manufactured by
- Advanced Chemical Industries PLC
Bivara Oral Solution
About Bivara 10 mg/ml Oral Solution
Bivara 10 mg/ml Oral Solution is a prescription medicine used alongside other treatments to control partial-onset seizures. It contains brivaracetam and is made by Advanced Chemical Industries PLC.
There are 10 brands of Brivaracetam listed in Bangladesh.
What is Bivara 10 mg/ml Oral Solution?
Bivara is an oral solution that belongs to a group of medicines called adjunct anti-epileptic drugs. It is used together with other anti-seizure medicines to treat partial-onset seizures. The active ingredient is brivaracetam. Bivara comes as a 10 mg/ml oral solution. It is made by Advanced Chemical Industries PLC. Seizure treatment is individual, so the doctor decides the right dose and course for each person. Always follow the doctor's instructions when taking Bivara.
Uses of Bivara
Bivara is used to treat partial-onset seizures, a type of epilepsy where seizures begin in one part of the brain. It is taken as an add-on to other anti-epileptic medicines, not usually alone. The doctor decides whether Bivara is suitable and how it fits with other treatments. Do not change or stop any seizure medicine without medical advice.
How to use Bivara
Take Bivara exactly as the doctor prescribes. It is an oral solution, so measure the amount with a proper measuring device as instructed by the pharmacist. The doctor decides the dose and how often it is taken. Do not change the dose on your own. If you miss a dose, ask the doctor or pharmacist what to do. Swallow or take the solution as directed, and keep all appointments for follow-up.
Side effects of Bivara
Common side effects include sleepiness or sedation, dizziness, tiredness, and nausea or vomiting. These may affect your ability to drive or use machines, so avoid these activities until you know how Bivara affects you. Tell the doctor if side effects bother you or do not go away. Seek immediate medical care for serious reactions such as mood changes, suicidal thoughts, breathing problems, or swelling of the face and throat.
Safety and precautions
Before taking Bivara, tell the doctor if you are pregnant, planning pregnancy, or breastfeeding, and if you have any allergies. The doctor should also know about all other medicines you take, as some can interact with Bivara. Do not stop Bivara suddenly without medical advice, as this can worsen seizures. Watch for changes in mood or behaviour, and contact the doctor if these occur. The doctor will decide if Bivara is suitable for you.
Frequently asked questions
How should I store Bivara oral solution?
Store Bivara at room temperature around 25°C, with short excursions between 15°C and 30°C allowed. Keep it out of reach of children. Do not use after the expiry date. If you are unsure about storage conditions, ask your pharmacist for advice.
What is Bivara used for and what kind of medicine is it?
Bivara is an adjunct anti-epileptic medicine used to treat partial-onset seizures. It is taken along with other anti-seizure medicines. The active ingredient is brivaracetam. It is available as a 10 mg/ml oral solution. Your doctor will decide if it is right for you.
What side effects should I watch for, and when should I call the doctor?
Watch for sleepiness, dizziness, tiredness, and nausea or vomiting. Call your doctor if these are severe or persistent. Seek immediate medical help for mood changes, suicidal thoughts, breathing difficulties, or swelling of the face and throat. Do not drive or use machines until you know how Bivara affects you.
Can I stop Bivara on my own?
No, do not stop taking Bivara or change the dose without talking to your doctor. Stopping an anti-epileptic medicine suddenly can cause seizures to worsen. The doctor will advise on how to adjust or stop treatment safely. Always follow the prescribed schedule.
Indications
Pharmacology
Brivaracetam binds SV2A with high affinity. SV2A is known to play a role in epileptogenesis through modulation of synaptic GABA release. It is thought that brivaracetam exerts its anti-epileptogenic effects through its binding to SV2A. Brivaracetam is also known to inhibit Na+ channels which may also contribute to its anti-epileptogenic action
Dosage & Administration
Based on individual patient tolerability and therapeutic response, the dosage may be adjusted down to 25 mg twice daily (50 mg per day) or up to 100 mg twice daily (200 mg per day).
Pediatric Patients (4 Years to less than 16 Years): The recommended dosage is based on body weight and is administered orally twice daily
Injection: for intravenous and adult use only when oral administration is temporarily not feasible; dosing is the same as oral regimen.
Interaction
Carbamazepine: Because of increased exposure to carbamazepine metabolite, if tolerability issues arise, consider reducing carbamazepine dosage in patients on concomitant Brivaracetam.
Phenytoin: Because phenytoin concentrations can increase, phenytoin levels should be monitored in patients on concomitant Brivaracetam.
Levetiracetam: Brivaracetam had no added therapeutic benefit when co-administered with levetiracetam.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Neurological Adverse Reactions: Monitor for somnolence and fatigue, and advise patients not to drive or operate machinery until they have gained sufficient experience on Brivaracetam.
Psychiatric Adverse Reactions: Behavioral reactions including psychotic symptoms, irritability, depression, aggressive behavior, and anxiety; monitor patients for symptoms.
Hypersensitivity: Bronchospasm and Angioedema: Advise patients to seek immediate medical care. Discontinue and do not restart Brivaracetam if hypersensitivity occurs.
Withdrawal of Antiepileptic Drugs: Brivaracetam should be gradually withdrawn.
Storage Conditions
Alternative brands of Brivaracetam
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.